NewsBenzingaResMed anticipe un BPA ajusté pour l’exercice 2027 de 12,00 $ à 12,25 $ contre 12,09 $ estimés ; anticipe un chiffre d’affaires de 5,750 milliards $ à 5,850 milliards $ contre 5,814 milliards $ estimés ResMed anticipe un BPA ajusté pour l’exercice 2027 de 12,00 $ à 12,25 $ contre 12,09 $ estimés ; anticipe un chiffre d’affaires de 5,750 milliards $ à 5,850 milliards $ contre 5,814 milliards $ estimés Benzinga 2026.10.29 21:31 (GMT+0) Open on Benzinga Other news How Everyday Investors Are Playing the Nvidia Drama Alvotech (ALVO) Presents at UBS Global Biopharma Conference 2026 Transcript Nvidia Tops Sales Forecast After Huang's Resignation Bill Gates Has Earned $2.6 Billion in Dividends From a Landfill Stock the EPA Keeps Citing for Methane Leaks, and a Filing Shows He Just Bought 3.7M More Shares Nvidia promises that revenue will keep soaring — for now CalPERS Discloses $37.1 Million Stake in Strategy
Bill Gates Has Earned $2.6 Billion in Dividends From a Landfill Stock the EPA Keeps Citing for Methane Leaks, and a Filing Shows He Just Bought 3.7M More Shares